Created By: Daylen Gargalis
Golden Rice: What it is, what it does and how good it is at doing it
Updated 6 April 2013. For articles on Golden Rice in scientific journals, please scroll down to a list of publications!
<< Home <<
Golden Rice is rice enriched with beta-carotene, a provitamin. It was developed to help prevent vitamin A deficiency and its often severe and sometimes deadly consequences in rice-eating populations in developing countries: in these countries many people are too poor to be able afford a balanced diet with greens, fruits and animal products. Unfortunately it is only realistic to assume that large parts of these populations will remain poor and malnourished for the foreseeable future.
Contents: Rice and vitamin A deficiency | Vitamin A interventions to date | Golden Rice as a new vitamin A intervention | Golden Rice as a humanitarian project | Timeline of Golden Rice | The burden of vitamin A deficiency in India | Impact and cost-effectiveness of Golden Rice | Publications
Rice and vitamin A deficiency
 Rice is a staple crop for half of humanity. In particular in Asia it is the main source of dietary energy for many people. Yet, rice is a poor source of some vitamins and minerals, e.g. unlike certain other crops it does not contain any beta-carotene (provitamin A). Therefore people who rely on rice as their main food source are at risk of vitamin A deficiency. This risk is biggest for pregnant and lactating women as well as for young children. The main consequences of vitamin A deficiency are (i) eye problems that can lead to complete blindness and (ii) a higher susceptibility to infectious diseases that are often deadly. In fact, the World Health Organization (WHO) estimates that each year 125,000-250,000 children die due to VAD, with as many becoming blind. In the poorest countries the WHO considers vitamin A deficiency to be one of the major health risk factors. And according to data of the latest study on the "Global Burden of Disease", in 2010 more than 11.5 million so-called "Disability-Adjusted Life Years" (DALYs) – i.e. person-years lost in a population owing to disability and shortened life – were lost globally due to VAD.
Vitamin A interventions to date
So far, efforts to address VAD rely mainly on the distribution of medical doses of synthetic vitamin A. Usually these supplementation programmes are targeted at pre-school children, who have to receive a vitamin A mega dose twice a year. While such interventions are considered to be very cost-effective, it represents a considerable cost to cover millions and millions of children two times year on year. Apart from these recurrent costs, which reduce the funds that are available for other humanitarian efforts, in developing countries there are additional problems that limit the coverage and success of such programmes (infrastructure, logistics, qualified health personnel). Children in remote rural areas or in urban slums may not be reached and older children and adults are not covered at all. Programmes for the industrial fortification (e.g. of sugar) face similar obstacles. And the promotion of nutrition knowledge and dietary diversification, while the most desirable option, is also the most long-term and resource-intensive intervention (for instance on the supply side such projects have high staff requirements and their geographic coverage is limited, while on the side of the beneficiaries there can be opportunity costs – especially in form of the time and costs it takes to cultivate or procure the required produce and to prepare the meals – that prevent an uptake).
 Golden Rice as a new vitamin A intervention
Therefore, despite what current efforts have already achieved, developing additional tools to help address VAD is a good idea per se – as long as these alternative interventions can make a difference in terms of impact and cost-effectiveness. This is where Golden Rice comes into play: While beta-carotene is produced in the green parts of the rice plant, none of it gets into the kernels. And if there is nothing, nothing can be used for cross-breeding, i.e. conventional breeding was not an option. Instead, rice was genetically engineered (with the help of a maize gene) to produce kernels that are enriched with beta-carotene. Like in other carotene-rich plants (e.g. carrots, mangoes or orange-fleshed sweet potatoes), this gives the Golden Rice its characteristic yellow hue from which its very name is derived.
Golden Rice as a humanitarian project
Golden Rice was originally developed by a team of researchers led by Ingo Potrykus of the Swiss Federal Institute of Technology and by Peter Beyer of the University of Freiburg in Germany. Later on the project was also supported by a group of seed companies, coordinated by Syngenta, who donated royalty-free intellectual property (materials and patented processes and technologies) for the development and humanitarian use of Golden Rice. For this reason – and contrary to often repeated claims by activists – smallholder farmers in developing countries will be able to get Golden Rice without additional charges and they are free to save the seeds for replanting. The work on Golden Rice is being continued and coordinated by the International Rice Research Institute (IRRI). Target countries for the introduction of Golden Rice are the Philippines and Bangladesh, but also India, Indonesia and Vietnam.
Timeline of Golden Rice
According to an NPR interview with Gary Toenniessen of the Rockefeller Foundation, the story of Golden Rice began in 1984 with an after-work brainstorming of a group of breeders at a meeting at IRRI. The idea that was discussed there – that regular white rice does not provide enough beta-carotene to protect children from vitamin A deficiency and that they can be harmed for the rest of their lives – persuaded Toenniessen to start a Rockefeller programme to develop "yellow rice". Other donors followed, such as the European Commission, but Rockefeller is still funding work on Golden Rice, such as field tests and bio-safety assessments.
Then, in 1999 a press release of the European Commission confirmed that "a project funded by the European Union – Carotene plus – has successfully incorporated the production of ß-carotene into rice. This major scientific achievement, which incidentally turns the rice grains yellow, will [sic!] help prevent severe vitamin A deficiency in countries relying on rice as a staple food." A year later, in 2000, a first proof-of-concept study on the feasibility of rice biofortification with beta-carotene was published, and in subsequent work the beta-carotene content in the rice was increased substantially: By 2005 a "second generation" of Golden Rice had been developed that could provide enough beta-carotene (even in in absolute terms) to prevent VAD in rice-eating populations. Not least, this advance served to disprove the "Golden Rice Hoax" (which is discussed in more detail in the references below).
By 2009 a feeding study had been conducted that showed a high bioavailability of the beta-carotene in Golden Rice, and in 2012 the results of another, larger feeding study showed that the beta-carotene in Golden Rice is as effective as pure beta-carotene and better than spinach at providing vitamin A to children. As IRRI – while itself not involved – pointed out, a statement in this latter study confirmed that the processes and protocol of the study were approved in China and the United States and the study was conducted with the consent of those involved.
Meanwhile not least the strict regulatory frameworks for the approval of GMOs slowed down the development process of Golden Rice, which was moreover met with scepticism by a public that was unsettled because of contradicting but unsubstantiated disinformation campaigns of interested third parties and activist groups that benefit from keeping the public in the dark – and frightened – about GM crops. (One reason why it is important to bring light into the discussion about GMOs.)
Continuing its previous funding, in April 2011 the Gates Foundation announced a US$ 10 million grant to IRRI to fund the development and evaluation of Golden Rice varieties for the Philippines and Bangladesh. The grant is also meant to help generating the data needed for Golden Rice to comply with food safety and environmental regulations. Thus the grant will also be used to compile the regulatory dossier to confirm that Golden Rice is indeed safe to eat; as the coordinator of the Golden Rice Network stresses: "These crops will not be used by farmers or consumers until they pass tests for biosafety in each country." In addition, this new initiative includes a collaboration of IRRI with Hellen Keller International (HKI) to evaluate to what extent the consumption of Golden Rice improves vitamin A status. Then, if Golden Rice is deployed, HKI will help ensure that it reaches those most in need.
In January 2013, two seasons of field trials were concluded in the Philippines. These trials were part of the safety assessment of Golden Rice and the generated data will be evaluated by the national regulatory authority in the Philippines for biotechnology research and development as part of their biosafety regulatory process. As Golden Rice will only be made available broadly to farmers and consumers in the Philippines if it is approved and shown to reduce vitamin A deficiency, this process may take another two years or more.
The burden of vitamin A deficiency
As explained above, and despite some shortcomings, current approaches to address VAD are cost-effective public health interventions. Therefore any alternative or additional vitamin A intervention should be less costly than these remedies, have a discernible impact, and possibly be complementary in scope to cover those people who are neglected so far. Together with an inter-disciplinary group of researchers I carried out a comprehensive case study for India to assess impact and cost-effectiveness of other biofortified crops and Golden Rice. (The work on Golden Rice was done with Dr. Sachdev and Prof. Qaim.) In a first step we measured the burden of disease of VAD by counting the number of "disability-adjusted life years" (DALYs) lost, i.e. the number of years of life lost due to ill-health, disability or early death because of VAD. In India the burden of VAD amounts to an annual loss of 2.3 million DALYs; as reported above, the global figure is 11.5 million DALYs lost due to VAD.
Impact and cost-effectiveness of Golden Rice
To determine the potential impact of Golden Rice on this burden on public health, we simulated the consumption of Golden Rice based on real food expenditure data from a representative sample of 120,000 households in India. We found that in a high impact scenario the widespread consumption of Golden Rice in the target groups could reduce the disease burden of VAD in India by almost 60 percent. But even under pessimistic assumptions the burden could still be reduced by almost 10 percent – i.e. over 200,000 "healthy life years" (DALYs) could be saved. Setting off these gains (in terms of saved lives and improved health) against all the costs needed to make Golden Rice a success (i.e. expenditures for research, breeding, dissemination, public awareness, etc.) showed that Golden Rice could prevent the loss of one DALY for less than $20, even under pessimistic assumptions. In contrast, other vitamin A interventions cost between $80-$600 per DALY saved. Hence, while this was only a computation, it was a very thorough one. (We worked on the overall project for three years and used all available information.) Therefore our conclusion was that pursuing the development of Golden Rice further is justified. The finer details of this study can be found in the peer-reviewed literature listed below, where common arguments against Golden Rice – which are based on double standards or twisted logic and poor data – are refuted point-by-point.
- Alexander Stein
More Sharing Services Share on facebook Share on twitter
<< Home <<
Publications on the impact and cost-effectiveness of Golden Rice
Please feel free to contact me if you cannot obtain the papers elsewhere.
Stein A.J., Sachdev H.P.S., Qaim M. (2008). "Genetic engineering for the poor: Golden Rice and public health in India." World Development 36(1): 144-158. doi:10.1016/j.worlddev.2007.02.013.
Stein (2008), Golden Rice, World Development Abstract: Vitamin A deficiency (VAD) affects millions of people, causing serious health problems. Golden Rice (GR), which has been genetically engineered to produce beta-carotene, is being proposed as a remedy. While this new technology has aroused controversial debates, its actual impact remains unclear. We develop a methodology for ex ante evaluation, taking into account health and nutrition details, as well as socioeconomic and policy factors. The framework is used for empirical analyses in India. Given broad public support, GR could more than halve the disease burden of VAD. Juxtaposing health benefits and overall costs suggests that GR could be very cost-effective. (Keywords: vitamin A deficiency, biofortification, Golden Rice, disability-adjusted life years, cost-effectiveness, India.)
Qaim M., Stein A.J. (2008). "Economic consequences of Golden Rice." Invited presentation at the 4th Conference of the European Plant Science Organisation (EPSO), 22-26 June, Toulon, France.
Qaim (2008), Golden Rice, EPSO Abstract: Golden Rice (GR), which has been genetically modified to produce beta-carotene in the endosperm of grain, has been proposed to control vitamin A deficiency (VAD), especially among the poor in developing countries. However, the usefulness of GR is questioned by some, and the technology has become one of the centerpieces in the public controversy over genetically modified crops [...] we show that VAD is a serious public health problem in India, causing a sizeable disease burden, especially in terms of increased child mortality [...] if GR were to be consumed widely, the disease burden of VAD could be reduced by 60% [...] Regardless of the underlying assumptions, GR is likely to be more cost-effective than alternative vitamin A interventions, such as food supplementation or fortification. Therefore, it should be considered seriously as a complementary intervention to fight VAD in rice-eating populations.
Stein A.J., Sachdev H.P.S., Qaim M. (2007). "What we know and don't know about Golden Rice." Nature Biotechnology 25(6): 624. doi:10.1038/nbt0607-624a, incl. a point-by-point refutation of arguments made against Golden Rice in response to our earlier study, and incl. an illustration of how such arguments are inconsistent and based on double standards.
Stein (2007), Golden Rice, Nature Biotechnology Abstract: Michael Krawinkel raises three issues in his comment to our economic analysis of Golden Rice. First, he questions the scientific basis of the assumptions that we have used in our impact assessment. Second, he claims that the development of Golden Rice costs “a lot of money” and would mainly benefit “agrochemistry” companies. And third, he states that biofortification in general and Golden Rice in particular cannot replace any of the established micronutrient interventions for the forseeable future. [... In response, we highlight the biomedical foundation and the available evidence for our assumptions; we put the costs of Golden Rice into perspective by citing the costs for alternative interventions, which are two orders of magnitudes bigger; we clarify the misconception that private companies would benefit from Golden Rice, which is a humanitarian undertaking; and more generally we illustrate how Krawinkel uses double standards in his criticism e.g. by stressing the costs of Golden Rice while ignoring the costs of other interventions, or by stressing the limitations of Golden Rice without acknowledging the shortcomings of alternative interventions (which Golden Rice could complement in a sensible way. Finally, we explain how our cost-effectiveness analysis, which uses uniform standards that create a level playing field and allow comparisons across interventions in a transparent and consistent way, represent a more objective and science-based approach.]
Stein A.J., Sachdev H.P.S., Qaim M. (2006). "Potential impact and cost-effectiveness of Golden Rice." Nature Biotechnology 24(10): 1200-1201. doi:10.1038/nbt1006-1200b. With supplementary information.
Stein (2006), Golden Rice, Nature Biotechnology Abstract: A News & Views article by Michael Grusak in last year’s April issue (Nat. Biotechnol. 23, 429-430, 2005) highlighted the unresolved debate concerning the efficacy of Golden Rice in addressing the problem of vitamin A deficiency (VAD). He pointed out that an assessment of the potential impact of Golden Rice on this type of malnutrition requires the consideration of multiple variables, including the target individuals’ life stages, the average amount of rice consumed daily by these individuals and the percentage of β-carotene that would be absorbed from rice. He further explains how early critics of the original Golden Rice technology had used simple estimates of these variables to suggest that unrealistic amounts of the transgenic rice would need to be consumed to satisfy the recommended dietary intakes of vitamin A equivalents (exclusively) through rice consumption. [...]
Stein A.J., Sachdev H.P.S., Qaim M. (2006). "Potential impact and cost-effectiveness of Golden Rice." Nature Biotechnology 24(10): online supplement, on p. 27 incl. a detailed point-by-point refutation of the populistic arguments made against Golden Rice in "The Golden Rice hoax."
Stein (2006), Golden Rice, Nature Biotechnology Abstract: Genetic engineering (GE) in agriculture is a controversial topic in science and society at large. While some oppose genetically modified crops as proxy of an agricultural system they consider unsustainable and inequitable, the question remains whether GE can benefit the poor within the existing system and what needs to be done to deliver these benefits? Golden Rice has been genetically engineered to produce provitamin A. The technology is still in the testing phase, but, once released, it is expected to address one consequence of poverty – vitamin A deficiency (VAD) – and its health implications. Current interventions to combat VAD rely mainly on pharmaceutical supplementation, which is costly in the long run and only partially successful. We develop a methodology for ex-ante evaluation, taking into account the whole sequence of effects between the cultivation of the crop and its ultimate health impacts. In doing so we build on a comprehensive, nationally representative data set of household food consumption in India. Using a refined disability-adjusted life year (DALY) framework and detailed health data, this study shows for India that under optimistic assumptions this country's annual burden of VAD of 2.3 million DALYs lost can be reduced by 59.4% hence 1.4 million healthy life years could be saved each year if Golden Rice would be consumed widely. In a low impact scenario, where Golden Rice is consumed less frequently and produces less provitamin A, the burden of VAD could be reduced by 8.8%. However, in both scenarios the cost per DALY saved through Golden Rice (US$3.06-19.40) is lower than the cost of current supplementation efforts, and it outperforms international cost-effectiveness thresholds. Golden Rice should therefore be considered seriously as a complementary intervention to fight VAD in rice-eating populations in the medium term. Plus, on p. 27, incl. a detailed point-by-point refutation of the populistic arguments made against Golden Rice in "The Golden Rice hoax." (Keywords: genetic engineering, beta-carotene biofortification, vitamin A deficiency, Golden Rice, health benefits, DALYs, cost-effectiveness, cost-benefit analysis, India.)
Stein A.J., Sachdev H.P.S., Qaim M. (2006). "Can genetic engineering for the poor pay off? An ex-ante evaluation of Golden Rice in India." Research in Development Economics and Policy 5, University of Hohenheim.
Stein (2006), Golden Rice, University of Hohenheim Abstract: Genetic engineering (GE) in agriculture is a controversial topic in science and society at large. While some oppose genetically modified crops as proxy of an agricultural system they consider unsustainable and inequitable, the question remains whether GE can benefit the poor within the existing system and what needs to be done to deliver these benefits? Golden Rice has been genetically engineered to produce provitamin A. The technology is still in the testing phase, but, once released, it is expected to address one consequence of poverty – vitamin A deficiency (VAD) – and its health implications. Current interventions to combat VAD rely mainly on pharmaceutical supplementation, which is costly in the long run and only partially successful. We develop a methodology for ex-ante evaluation, taking into account the whole sequence of effects between the cultivation of the crop and its ultimate health impacts. In doing so we build on a comprehensive, nationally representative data set of household food consumption in India. Using a refined disability-adjusted life year (DALY) framework and detailed health data, this study shows for India that under optimistic assumptions this country’s annual burden of VAD of 2.3 million DALYs lost can be reduced by 59.4% hence 1.4 million healthy life years could be saved each year if Golden Rice would be consumed widely. In a low impact scenario, where Golden Rice is consumed less frequently and produces less provitamin A, the burden of VAD could be reduced by 8.8%. However, in both scenarios the cost per DALY saved through Golden Rice (US$ 3.06-19.40) is lower than the cost of current supplementation efforts, and it outperforms international cost-effectiveness thresholds. Golden Rice should therefore be considered seriously as a complementary intervention to fight VAD in rice-eating populations in the medium term. (Inclusive of a scientific appraisal of the populistic arguments gathered by Vandana Shiva in "The 'Golden Rice' hoax" - which are, for instance, more widely circulated and exploited by Greenpeace.) (Keywords: genetic engineering, beta-carotene biofortification, vitamin A deficiency, Golden Rice, health benefits, DALYs, cost-effectiveness, cost-benefit analysis, India.)
Stein A.J., Sachdev H.P.S., Qaim M. (2006). "Potential impacts of Golden Rice on public health in India." Contributed paper presented at the 26th Conference of the International Association of Agricultural Economists (IAAE), August 12-18, Broadbeach, Australia.
Presentation on Golden Rice [PDF | 54KB].
Stein (2006), Golden Rice, IAAE Abstract: Vitamin A deficiency (VAD) affects millions of people world-wide, causing serious health problems. Golden Rice (GR), which has been genetically engineered to produce beta-carotene, is being proposed as a remedy. While this new technology has aroused controversial debates, its nutritional impact and cost-effectiveness remain unclear. We determine the current burden of VAD in India from a public health perspective, and simulate the potential alleviating impact of GR using representative household food consumption data. Given broad public support, GR could more than halve the overall burden of VAD. Juxtaposing health benefits and overall costs suggests that GR is very costeffective. (Keywords: Golden Rice, vitamin A deficiency, biofortification, genetic engineering, DALYs, cost-effectiveness analysis, India.)
Stein A.J. (2006). "Potential impact and cost-effectiveness of Golden Rice in India: an ex-ante study." Invited presentation at the Meeting of the Golden Rice Humanitarian Board, May 2, Freiburg i.Br., Germany.
Presentation on Golden Rice [PDF | 113KB].
<< Home <<
Copyright © 2005-2013 Alexander Stein.
StatCounter - Free Web Tracker and Counter
Category: Resarch source spring paper | Comments: 0 | Rate:
Created By: Daylen Gargalis
TracHave (One word?)
you ever wondered if people who are
high are realizing what harm they are doing to their body as well as
there brain? Before this project, I had always thought the outcome of
marijuana was used to only get someone high. After completing this
project, I now realize that the effects of marijuana are much more than
that. Marijuana has huge effects long and short term on the human brain
as well as the human body. Abusers are choosing to take many risks when
deciding to get high. Research has proven that the use of marijuana
negatively affects the human brain as well as the human body.
Marijuana comes from hemp flowers of the cannabis sativa that are
shredded and dried. You may not know the drug by its correct term, but
maybe by its slang term. Maybe you know the drug by the name of weed,
pot, or even Mary-Jane.The chemical found in marijuana is known as
THC,delta-9-tetrahydrocannabinol. This chemical, is also known as a
cannabinoid chemical (Bonoser 2013 12)
can do much harm to the human body as well as the brain if the drug is
abused. "Many first time users, smoke marijuana to experiment with it.
When a user smokes marijuana, the THC chemical enters the lungs. Passing
through the lungs, the THC enters the bloodstream, which carries the
chemical to the human brain (Millwork 2013 2
Majority of these people do not become addicted to the substance. When
smokers do become addicted, it is rather easy for them to quit.
Marijuana has a very limited amount of withdrawal symptoms, making the
quitting process easier. (Gumbiner 2010 1,2)
Marijuana's short term side effects eventually wear off. They
usually last for about 24 hours. Of course, the high you get from the
Chemical THC What is it?
wears off. After users smoke marijuana, the have the
feeling of feeling relaxed. They feel as if they have escaped all their
problems. Some short term side affects that eventually wear of are as
followed: feelings of intoxication, relaxation, altered perception of
time and distance, intensified senses, laughter, talkativeness, a
decrease in anxiety as well as alertness (Tracey 2013 7
). Sleepiness as well as reddening of the eye can occur. Most users
suddenly have a greater appetite. Users can loose sense of the time.
There vision and hearing become affected. Using marijuana regularly, can
lead to the use of other substances as the main way the user copes with
life, making their chances of using another substances even higher than
those who don't use the drug (anonymous 2013 9
Marijuana can also harm your immune system. It limits your body and can
cause your body to be unable to fight off viruses as well as it diverse
types of cells in the body. Because of this, your chances of screening
out cancers cells and eliminate infectious diseases are very limited (annoymouse 2013 10
). Many short sentences
Marijuana also includes long-term side effects. Studies have proven, the
lungs as well as heart rate was affected by frequent use. frequent
users, have a high risk of affecting their immune system, heart, lungs,
and reproductive system. New users, within the first 2 to 3 hours have a
20%-100% rise in heart rate.(Tracey 2012 1
it comes to their reproductive system, in both men and woman
hormones may be affected. It can even cause a delay in puberty for young
men. For females, when marijuana has become a daily use or used
multiple times, it can cause a disruption to our monthly
menstrual cycles and eggs may not be released from our ovaries. (annoymouse 2013
men smoke marijuana they sperm count decreases massively. Decreased
circulating testosterone levels come into play, as well. When females
choose to smoke during their pregnancy, their babies weigh less, are
shorter, and have smaller head circumferences at birth (Committee on Substance Abuse 2013 (journa
l 5)". When users smoke marijuana there eyes can dilate. This can cause colors to appear more intense.(Bonoser 2013 1
are at risk for possible heart attack, heart failure, and even stroke..
When the smoke is inhaled, it goes to your lungs. This may cause lung
cancer. One study had found that over an 8-year period, respiratory
health had shown a greater decline among marijuana smokers than among
tobacco users. When marijuana is smoked, 1/3 more tar is deposited into
the respiratory tract compared to tobacco smoking (Tracy 2013 2
it comes to a users emotions, many of them become suicidal or very
depressed.Weekly users, can double their risk of depression later on
life. (annoymouse 2013
Many frequent users also experience panic attacks. Marijuana doesn't
just affect your body and brain but limits your social life. "Many
abusers are affected at school, work, with family issues, recreational
and social activities. Impaired thinking occurs as well. (millwork 2013 8
For many, school either becomes too difficult for them or they just
don't care anymore. "Several studies have shown, workers whom smoke
marijuana have an increase in absences and job turnovers. For example, a
study among postal-workers found that employees who had tested positive
for marijuana use on a pre-employment urine drug test, had 55 percent
more industrial accidents, 85 percent more injuries, and a 75 percent
increase in absenteeism compared to those who have tested negative for
marijuana use (annymouse 2013 3
"Adults who smoked marijuana daily believed it helped them function
better, improved self-awareness and improved relationships with others.
However, researchers found that users were more willing to tolerate
problems, suggesting that the drug served as a buffer for those who
would rather avoid confronting problems than make changes that might
increase their satisfaction with life. The study indicated that these
subjects used marijuana to avoid dealing with their difficulties and the
avoidance inevitably made their problems worse. Although users believed
the drug enhanced understanding of themselves, it actually served as a
barrier against self-awareness (annoymouse 2013 9
)". Many short sentences. Combine some
Research has proven, the memory deficits following the use of marijuana
are the major adverse effects of this widely abused drug. "Marijuana
exprosure produces many long-term disruption on the human brain. The
many memory deficits that are produced by the marijuana arise via
interaction of the psychoactive component (Hoffman, Oz, Yang, Lichtman, Lupica 2013
)". A group of researches did an experiment to test the effects of
Marijuana on the attention span of those who use the drug vs. those who
do not use the drug. Before they had proceeded on with the
experiment, MRIs were performed on the subjects. The results from the
MRIs had shown decrease in grey matter but an increase in white matter.
There was a smaller amount of whole grey matters. Studies showed, that
the marijuana users demonstrated an altered brain activation compared to
the subjects who did not smoke marijuana. The brain regions that had a
decrease in brain activation across both of the marijuana groups
included the following: right lateral prefrontal, DMP, and medial
cerebellar brain regions. The Cerebellum is involved in multiple
attention requiring tasks. The researches conducted more testing on
these individuals. The researches tested all the subjects
urine. The subjects who had tested with positive urine had shown greater
activation in the medial front regions, parietal regions, and the right
medial cerebellum (Chang, Yakupov, Cloak, Ernst 2013
"A good working short memory, is well needed to learn as well as to
perform tasks that call for more than one and or even two steps (annoymouse 2013 11
Studies have also shown, that those smoking the substance, people have
shown the same lack of coordination and ability on a standard "drunk
driver" test as do those who have had too much alcohol to drink (annoymouse 2013 12
Another experiment had been performed, and new results had
appeared."Researchers had experimented whether the age of use was
related to the cumulative THC exposure What is it?
. The findings had proven that the
greater cumulative THC exospore lead to the lower brain activation in
the medial cerebellum. The effects had turned out to be even more severe
in the individuals whom had first used the drug at a younger age,
possibly in their teens or even younger (Chang, yakupov, Cloak, Ernst 2013
10 )". "The earlier teens do begin to smoke marijuana, the more likely they are to become dependent later on throughout life (annoymouse 2013 8
has also shown, adolescents who choose to use marijuana are 104 times
more likely to use cocaine compared to those who have never smoked
marijuana before (Comitee On Substance Abuse 2013 7
Inside your brain, you have cannaboid receptors that are found in the
cerebellum. "It was not till the 1990s that cannabinoid receptors in the
brain, responding to THC, were discovered (Tracy 2013 4
"The cannabinoid receptors control your emotions, your mood, memory,
thinking and much much more These cannaboid receptors are affected
causing coordination, sensory perception, time perception,
concentration, memory and pleasure to be out of whack. When marijuana is
inhaled or smoked the THC flows into the bloodstream up to the
cannabinoid receptors located in your brain. "When THC comes into play,
if overtakes the endocannabinoid system and this is when the high takes
places. (millwork 2013 2
)". "Research had shown that THC exerts all of its known central effects through the CB1 cannaboid receptor (Iversen 2013 1
)". Another location of the cannaboid receptors are located in your immune system. (annoymouse 2013 4)
"When the cannaboid receptors are harmed or disrupted, your short-term
memory, coordination, learning and problem solving are harmed. (Bonoser 2013 8,9,10,11)
From the harmful chemical found in the substance, the gray matter found
surrounding neurons begins to deter ate after a certain period of
time. Many users start off at a young age, because of this many of their
IQ levels drop. Marijuana abusers are also at high risk for
schizophrenia, anxiety, and depression. THC affects your corpus collosum
which controls your emotions. "Cannabinoid receptors are activated by a
neurotransmitter called anandamide. Anandamide belongs to a group of
chemicals called cannabinoids. THC is also a cannabinoid chemical. THC
mimics the actions of anandamide, meaning that THC binds with
cannabinoid receptors and activates neurons, which causes adverse
effects on the mind and body (Bonoser 2013 12
"High concentrations of cannabinoid receptors exist in the hippocampus,
cerebellum and basal ganglia. The hippocampus is located within the
temporal lobe and is important for short-term memory. When the THC binds
with the cannabinoid receptors inside the hippocampus, it interferes
with the recollection of recent events. THC also affects coordination,
which is controlled by the cerebellum. The basal ganglia controls
unconscious muscle movements, which is another reason why motor
coordination is impaired when under the influence of marijuana (Bonoser 2013 13
)". add What are some of these things are
When choosing to smoke marijuana, along with the side affects there are
many risks your opting to take. You could have a huge decrease in your
performance during your sports. This is caused by the powerful chemical
THC. Your increasing your risk with getting in trouble with the law.
Smoking marijuana is linked to increase in panic attacks. You could very
easily do something that embarrasses yourself or even hurt you. For
example, driving under the influence or even engaging into risky sexual
behavior leading you to increase your chances of catching sexually
transmitted diseases. You could loose interest in your appearance as
well (annymouse 2013 1,2,3,4,6
frequent users make the decision to quit, they face multiple
withdrawals. They may crave the substance for long periods of times.
They can have trouble sleeping. Another withdrawal may include a
decrease in appetite. Luckily,
overtime, these symptoms frequent users
experience slowly go away within a couple weeks of quitting (Millwork 2013 12,14
So, the next time you go to smoke that joint remember the negative
outcomes as well as the risks your taking. Is it worth endangering your
cannaboid receptors, becoming at high risk for a possible heart attack
or even possible stroke? Or the risk of becoming addicted. Always
remember once addicted quitting is hard but is always an option. Take
the road that's less traveled. Be smart and choose the correct thing to
do. So the next time you go to smoke that joint, as yourself the
following: If the short term side effect, the high, worth the long term
effects on your brain and your body?
A little jumbled up
Anonymous is spelled wrong.
As you mentioned, hyperlinks need to be fixed
You tend to just list off chemicals. Add an explaination of what they are
Category: My peer edits | Comments: 0 | Rate:
Created By: Daylen Gargalis
Imagine one treatment to repair and
reconstruct the body from illnesses such as Alzheimer's, preventing
extinction of endangered species and maybe even cure aging. Scientists
may have found a way to cure specific illnesses and failing organs by
replacing organs and cloning cells, but of course there are many
obstacles to surpass. There are many people that are against this type
of research for many reasons, some even false and blocking the way for
science to thrive. Stem cell research without a doubt makes you think
for yourself, and has great, promising outcomes in the near future. Clarify thesis and plan.
A) Backround info on stem cells
There are two types of stem cells and both are found in every living
organism. Embryonic stem cells are are responsible for developing a
mammal to maturity. Adult stem cells (which ones)
are responsible for repairing the
body after maturity. Both types are thought to be able to treat a great
number of illnesses by pushing the body to repair itself (Anonymous B, 1
There are already some uses of these cells proven to benefit patients.
When one has Leukemia a more advanced way of treating the illness is a
transplant of bone marrow to help slow down the incapacitating condition
of the patient. Also, researchers believe that cultivating stem cells
can give more possibilities to the treatment of many other illnesses
including patients with strokes, Alzheimer’s disease, and Parkinson’s
disease (Anonymous B, 2
Although adult stem cells have proven very useful for some diseases,
they have not been capable of producing as many cell types as embryonic
stem cells (Weiss 2008, 1
On the other hand few question the ability of embryonic stem cells.
Heart disease, the biggest killer in United States, may be cured with
embryonic stem cells. They can be trained to grow into heart muscle
cells that clump together and pulse in astonishing union. These cells
have been tested with mice and pigs and when injected they fill in for
injured or dead cells then speeding up recovery. Also studies have
prompted a stem cells potential for curing other illnesses such as
diabetes and spinal cord injury (Weiss 2008, 2
). Explain more
B)Effects on patients
This method of repairing the body seems very promising, although there
is one big question which is, is there any risks on the patient. Some
are worried because of animal research showing that in some cases
embryonic stem cells form into tumors or may change into unwanted types
of tissue. An example of the unwanted tissue would be the formation of
bits of bone in for example a heart that the cells are supposedly
repairing. Supporters respond to this saying that these occurrences are
rare and much has been learned on how to prevent this, and of course as
well as many other matters practice and study lead to perfection. (Weiss
) Says "Their
approaches vary, but on one point, all seem to agree: How humanity
handles its control over the mysteries of embryo development will say a
lot about who we are and what we're becoming."
Also, others against this study say that it may easily cause cancer in patients(Anonymous B, 2
The greatest risk human cloning poses is on the health of babies born
with this procedure if experimented with the technology we have today.
Experiments with animals have shown that although the cloning of an
animal is possible a great number of newly born animals die in early
development stages or a short time after birth. Additionally a great
part on these animals are born with defects. Other than unreliable
claims, human cloning has never been performed but a big possibility is
that human clones will likely have birth defects. One possible cause for
these defects are external influences other than genes(Pedro 2012, 2
C)Evidence of cloning
Therapeutic engineering is part of the larger rising field of
regenerative medicine. This also includes the extraction of stem cells
from adult tissues and application to ill conditions. This method
involves collecting cells from the patient, then creating cells capable
of forming many types of cells, developing the cells for the appropriate
type of tissue, multiplying these cells, and finally implanting these
cells back into the body. This process also shows that there is a
possibility of obtaining cells this way and replacing dying neurons to
treat the illness Alzheimer's, and maybe even treat aging with stem
cells. Also, it is possible to correct genetic errors in stem cells,
therefore making new treatments for patients with genetic
illnesses(Pedro 2012, 3
The beginnings of stem cell research can be traced back to 1963 in China
when the late embryologist transferred DNA from a male Asian carp cell,
a freshwater fish, to an egg of a female Asian carp. This process
produced the worlds first cloned fish.researchers had cloned other
organisms such as micro-organisms, nematodes and amphibians in previous
decades but never an organism so complex as Dizhou Tong did. The
experiment appeared to be entirely successful and even the cloned fish
created a tiny carp. He continued his work and after 10 years Tong
inserted the DNA of an Asian carp into the egg of a European crucian
carp created the first interspecies clone. Based on this mans research
Chinese scientists developed breeding methods so great that the nation
now makes half of the world's agriculture harvest (Liao 2007, 2
). Think about adding more sources
October 2011 is a day marked for the first stem cells created from human
clones. Although these cells were not normal and wouldn't work in stem
cell therapies because they had three sets of chromosomes, two from the
adult cell and one extra from the egg, this still was a breakthrough and
may lead the way to the treatments of so many promising treatments from
these cells which is the dream of many scientists (Brown 2011, 1
Human embryos are the base of the stem cell studies which is why women
are a great contribution in this field, although there are few donors
and scientists are in great need for them. (Brown 2011) says "The
authors' approach represents the first step towards acknowledging women
as genuine participants -- co-producers even -- in the generation of new
knowledge." On the other hand we need to find a way of obtaining
embryos for studies another way that does not put young women at risk
and may also help obtaining more embryos (Brown 2011, 4
). Check the hyperlinks.
In 1997, Ian Wilmut and others at the Roslin Institute in Scotland
invented a synthetic method of obtaining mammalian clones from mature
animals therefore allowing asexual reproduction with mammals. A sheep
named Dolly was the first mammal formed with this method although
cloning had been done in other species including frogs. The basic
concept of cloning is removing the nucleus of the mother cell, then
injecting the cell in an egg without a nucleus. Delicate cell conditions
and at times electric shock allows the nucleus to come together with
the egg to be inserted into the womb and generate a new organism in some
cases. This method of cloning is called nuclear transfer and has been
performed with many other species in recent years. With all of these
organisms this method makes them have the same nuclear genome of the
mother(Pedro 2012, 5
Nuclear transfer is already being put to good use. This method has been
used in agriculture for cloning a disease-resistant bull that had died
and cloning the Mouflon lamb a member of an endangered species of
sheep. The cloning of endangered species is a rising anticipation for
conservation efforts (Pedro 2012, 1
It is possible to acquire stem cells from adults without the need of a
blastocyst. However, these adult stem cells are less powerful and have
more limited applications as embryonic stem cells do. Although the
embryonic stem cells are the ideal one for research there may have
recently emerged an alternative with a technique called pluripotency
which allows adult stem cells to be transformed into pluripotent cells
which are capable to develop several different cell types. Although this
brings great excitement to scientists across the world this method is
not yet proven to be safe for the clinic.
D)Evidence of obstacles
Many oppose the research and experiments with stem cells for a number of
reasons. This is where religion, politics, and the people argue over
this topic and whether or not this should be allowed. There are many
ideas over this topic for example one may say that stem cell research
should be allowed but only to a certain extent not permitting human
cloning but the regenerating of dead tissue and cells is allowed. Others
have also related this idea to abortion but this is misleading for the
reason that an individual is not destroyed to generate embryonic stem
cells. The process uses a cellular mass known as a blastocyst which will
not develop an individual. These misleading ideas are slowing down the
research that one day may save the lives of thousands of people (Pedro
Some countries such as Germany have already prohibited some stem cell
research worrying about unethical human experimentation. Other countries
as well as the U.S. have set strict limits on the government funding of
stem cell research although the private sector has been left to do as
it wants. Other countries including China, U.K., Singapore and Korea
have set out to become the center of activity for stem cell research,
providing funds for the research and encouragement as well as boundaries
(Weiss 2008, 4
China has recently been increasing its effort in stem cell research and
practicing the field. A basic research part is the research of bone
marrow and embryonic stem cells. Hospitals have recorded the application
of stem cell treatment to illnesses such as heart failure, liver
failure and lower limb ischaemia. what?
Therefore, China is the most liberal
and ideal environment for human embryonic stem cell research.(Liao 2007,
However, the Chinese government is allowing research on human embryos
and cloning to continue for therapeutic purposes. In 2001, committees
from around China came together and suggested proper guidelines on human
embryonic stem cell research. They banned buying and selling of human
embryos for commercial purposes and reproductive human cloning which is
what most nations banned. The establishment of a new organization was
also proposed that centralizes the respectable research of stem cells in
China. Human reproductive cloning was not permitted at all in these
guidelines and on December 24,2003 these guidelines were enacted by the
Ministry of Science and Technology and Ministry of Health in China (Liao
There are also other obstacles that scientists encounter when studying
stem cells outside of laws. Obtaining embryos is very difficult when one
is not able to buy them from someone, and donors are very rare maybe
even only having one per year. It is difficult to get donors when others
are offering to pay for embryos for reproduction and of course people
rather get paid for their embryos (Brown 2011, 2
The New York team that created the first stem cells from human clones
had bought the embryos they used. To try and avoid any problems the
group offered the donor $8,000 for the time and risk of the process and
after let her decide whether to donate for reproduction or study. This
was obviously more convincing for the women (Brown 2011, 3
Overall, stem cell research is shows how much we can improve our
medicine and the promising scientific breakthroughs that this study has
in store for us in the near future. With stem cells we may be able to
heal all kinds of illnesses and maybe even cure aging. Scientists can
not do all this by themselves in the circumstances right now so that's
why we need your help. Step up and be part of this revolutionary study!
Add more to conclusion
Need more authored sources
Category: My peer edits | Comments: 0 | Rate:
Created By: Daylen Gargalis
"I sleep—for a while—two or three hours—then a dream—no—a nightmare
seizes me in its grip . . . I sense it and I know it . . . and I am also
aware that somebody is coming up to me, looking at me, running his
fingers over me, climbing onto my bed, kneeling on my chest, taking me
by the throat and squeezing . . . squeezing . . . with all its might,
trying to strangle me. I struggle, but I am tied down by that dreadful
feeling of helplessness that paralyzes us in our dreams. I want to cry
out—but I can't. I want to move——I can't do it. I try, making terrible,
strenuous efforts, gasping for breath, to turn on my side, to throw off
this creature who is crushing me and choking me—but I can't! Then,
suddenly, I wake up, panic-stricken, covered in sweat. I light a candle.
I am alone." - Guy de Maupassant (Cheyne 2013, 7
Recent experiments have shown that activation of the neurotransmitters
GABA and glycerine in REM sleep initiates motor atonia, which may still
be intact while one is awake. This experience, known as sleep paralysis,
can be horrifying. This essay will preview a brief background of sleep
paralysis, causes of paralysis, formation of hallucinations, and
possible treatments for sleep paralysis. It would be better to just say what you will do. Not say "this paper" or "this essay".
Sleep Paralysis is a temporary skeletal muscle paralysis that normally
occurs when one is waking up, but may also occur as one is falling
asleep (Cheyne and Pennycook 2013, 1
, Anonymous 2012, 8
Muscle paralysis, or motor atonia, usually lasts a few minutes or even
seconds, but one may feel as though they are paralyzed for hours as they
are aware of their inability to speak or move. The only muscles able to
move are the eyes and any non-voluntary muscles such as the diaphragm
(DeGuzman et al. 2010, 5
, Sharpless et al. 2011, 2
Since one's eyes are fully functional (as they are controlled by the
cranial nerves), one is aware of their physical surroundings and can
often project their dreams into their rooms. Those experiences are
called hypnagogic or hypnopompic hallucinations, and occur in an
estimated 20 percent of sleep paralysis episodes (Morton 2010, 6
Hypnagogic hallucinations are those that occur as one falls asleep. In
contrast, hypnopompic hallucination refer to those that take place as
one wakes up (Cheyne 2013, 8
Considering that one feels vulnerable and sees paralysis as abnormal,
hallucinations are often realistic and horrific (Anonymous 2012, 9
). The hallucinations can be split into 3 categories: intruder, incubus, and vestibular-motor experiences.
"I suddenly could not move.... I heard two distinct
voices: One was a demonic woman that said "we should have never let you
get away from us"... I struggled and struggled and felt my mouth moving
and calling my sister Rose... After what seemed like an eternity, the
pressure suddenly left and I got up. I ran downstairs and asked Rose if
she could hear me calling her name, she said No" (Anonymous 2007, 1
). Change to box format.
visual, auditory, and tactile sensations
contribute to strong feelings of the presence of another being in the
room, such as the one described in the quote above, are known as
intruder experiences (Cheyne and Pennycook 2013, 4
The victim may see a shadowy figure dash across the corner of their eye
or may hear faint whispers along with nearing footsteps, but no
creature truly invades their privacy.
Though the diaphragm is functioning properly, breathing is automatic and
cannot be controlled by a victim of sleep paralysis. This may trick the
victim into believing that they are suffocating (Cheyne 2013, 16
hallucinations involve feelings of intense chest pressure, suffocation,
and near death experiences (Cheyne and Pennycook 2013, 5
These experiences are often called "old hag attacks" because one often
sees a demonic figure, such as a witch, sitting on one's chest, as
described in the quote by Guy de Maussipant (MacKinnon 2013, 2).Where's the quote? Think about adding it.
Vestbular-motor experiences are much less frightening than intruder and
incubus because they focus on one's body instead of the sensed presence
of a devilish creature (Cheyne and Girard 2008, 4
Vestibular-motor hallucinations consist of illusory movement
experiences (IMEs) and out of body experiences (OBEs). IMEs include
feelings of floating, flying, falling and motor hallucinations. Motor
hallucinations are those in which one believes they moved a limb or even
their whole body until they realize that they were paralyzed (Cheyne
and Girard 2008, 13
According to an experiment in 2008, are more common than OBEs which
involve seeing one's body from up above and alienation from one's body
(Cheyne and Girard 2008, 3
Even after the brief period of extended motor atonia has worn off, one
may suffer from post-episode distress (a lingering feeling of anxiety)
(Anonymous 2012, 11
Scientists have uncovered a strong connection between fear and the
intensity of the hallucinations to post-episode distress (Cheyne and
Pennycook 2013, 13
Sleep paralysis is quite common seeing that over 50 percent of the world
population will undergo 1 or more episodes of sleep paralysis (Morton
Even then the experience is seemingly foreign and abnormal. For that
reason, people often seek supernatural explanations and describe their
hallucinatory incident as encounters with the devil, demons, and even
aliens. Different cultures have different explanations for
hallucinations. For example, Africans interpreted the episodes as acts
of voodoo magic from zombies while Europeans often believed the evil
creatures were witches (MacKinnon 2013, 3
Supernatural beliefs about sleep paralysis date back to 1781 and
further. In 1781, Henry Fuseli painted "the Nightmare" which represents
sleep paralysis itself. "The Nightmare" portrays incubus hallucinations
the portrait has a woman lying immobilized and a demon sitting on her
chest as though trying to suffocate her (MacKinnon 2013, 1
not fully proven, some scientists believe that the vividness of an
episode, among other factors, may push forth supernatural beliefs
(Cheyne and Pennycook 2013, 15
Sleep paralysis and its effects are widely known, but the causes of the episodes have only recently been studied. Have this as your topic sentence or add more
Sleep remains the primary cause of sleep paralysis. The sleep cycle is
divided into 5 stages: 4 of non-rapid eye movement (NREM) and 1 of rapid
eye movement (REM). NREM is the period of sleep in which brain waves
are slowed as the body regenerates and repairs itself; each of the 4
stages lasts for 5 to 15 minutes for a total of 90 minutes (Johnson
one drifts into stage 1 of NREM sleep, one experiences a falling
sensation which may be followed by an abrupt muscle contraction (Johnson
). While in stage 2 (light sleep), the body slowly adjusts to stages 3 and 4 of deep sleep (Johnson 2012, 4
The final stage is a 10 minute period of REM. As the cycle repeats
itself, REM periods grow longer. REM is the stage of sleep in which
dreams occur and, according to EEG recordings, brain waves are similar in speed to those during wakefulness ( Johnson 2012, 7).
The REM portion of one's sleep is where motor atonia occurs as a result
of dreams. Within a dream, one is constantly moving, therefore one's
central nervous system (CNS) is sending frequent motor instruction to
the body (DeGuzman et al. 2010, 4).
In order to prevent a person from reenacting their dream, signals sent
from neurons to cells called nerve impulses must be blocked, thus
paralyzing the person (Anonymous 2012, 2).
Nerve impulses occur in 5 steps: resting potential, action potential,
repolarization, hyperpolarization, and the refractory period. A neuron
is in resting potential when it is polarized. During polarization, the
neuron is not stimulated (Wiley 2013, 2).
Polarized nerve cells contain potassium with a negative charge on the
inside of the cell membrane and sodium with a positive charge on the
outside (Wiley 2013, 3).
When a stimulus is presented, the neuron's gated channels (channels in
the membrane of a neuron that open and close) permits positive sodium
ions to enter the cell turning the inside positive. This is called
action potential (Wiley 2013, 4).
Repolarization comes after the action potential as the cell membrane
allows negative potassium ions to exit the cell (Wiley 2013, 5). Hyperpolarization then takes place as there are more potassium ions outside than there are sodium ions inside (Wiley 2013, 6).
After the impulse passes through the neuron, potassium ions return
inside and sodium ions return outside the cell in the final step called
the refractory period (Wiley 2013, 7, 8).
In order for this process to take place, neurotransmitters (chemicals produced within neurons) are necessary to transport the impulse across synapses (Cherry 2013, 1, 5). As
an inhibitory neurotransmitter, gamma-Aminobutyric acid (GABA) reduces
neuron activity by blocking upcoming action potentials therefore
stopping impulses (Wiley 2013, 9). The
blockade formed by GABA, however, is not enough to paralyze a person.
According to Patricia Brooks and John Peever (2012, 8), the inhibitory neurotransmitters glycerin and GABA must both block impulses in order to initiate REM motor atonia.
Sometimes, GABA and glycerin continue to block nerve impulses even
though it is no longer necessary. In other words, REM motor atonia
extends into wakefulness therefore creating sleep paralysis episodes
(Brooks and Peever 2012, 13
Neurologists were able to find the cause of sleep paralysis, but what
induces hypnagogic and hypnopompic hallucinations? James Cheyne and Todd
Girard (2008, 6) suggest sleeping in the supine position (face up) is a
general cause of hallucinations, but what happens within the brain to
trigger such vivid experiences?
Though not all scientists agree, the amygdala is fundamental to conjure
hallucinations during sleep paralysis. The amygdala (plural form
amygdalae) are 2 small, almond-shaped masses of grey matter located
inside the brain. The "threatactive vigallince system" as James Cheyne
calls it, is responsible for one's response to intense emotions
(including fear) as well as remembering these emotions. Fear is a
necessary part in both animal and human development because it allows
the organism to detect danger (Cheyne 2013, 5
). During sleep, the amygdala is heightened (Morton 2010, 8
As explained above, one feels as though they are defenseless during
paralysis thus creating immense fear within the victim. The amygdala
interprets the fear and releases the hormone adrenaline (Takahashi 2008,
). The abundance of adrenaline increases the heart and respiratory rates (Takahashi 2008, 5
Blood pressure in the brain also increases causing change the the
visual and/or auditory cortex, creating a hallucination (Takahashi 2008,
In other words, a victim's eyes and/or ears respond to an absent
stimulus. Also an effect of fear, the victim's pupils dilate, meaning
the pupils widen to let more light in, and allow the person perceive
threat (Takahashi 2008, 7
Sleep paralysis has no known cure, but it can be treated. Understanding
which groups of people are more susceptible to sleep paralysis helps
when treating victims.
Possible factors that increase sleep paralysis susceptibility include depression, anxiety, and stress (Cheyne and Pennycook, 14
). Antidepressants used to treat these personality disorders have also been found to control the severity of episodes.
Sleep paralysis is a known side effect of narcolepsy, a disorder in
which people fall asleep in any given time. Regular ways of coping with
narcolepsy has shown positive effects on managing sleep paralysis among
narcoleptic patients. Narcolepsy can be controlled by taking regular
naps throughout the day, engaging in regular exercise, and enforcing a
healthy sleeping pattern (Anonymous 2012, 15
Studies that show students are more prone to experience these brief
episodes than the general population indicate stress and lack of sleep
are potential inducers (Sharpless et al. 2011, 3
People should avoid stressful situations and receive the recommended
amount of sleep for their age. Ways to improve sleep include creating a
comfortable sleep environment, avoiding caffeine intake, and abandoning
smoking habits. Regular exercise and healthy eating habits also
contribute to more peaceful sleep (Anonymous 2012, 13
Nationality plays a major role in susceptibility as well. Considering
that people of African or Asian origin are more inclined to paralysis
than those of Caucasian lineage, they should ensure that other factors
that increase sleep paralysis susceptibility do not apply to them
(Sharpless et al. 2011, 6
In conclusion, sleep paralysis is caused by sleep, hypnagogic and
hypnopompic hallucinations are formed by the amygdala, and treatments
for sleep paralysis can be found by understanding susceptibility.
Prolonged motor atonia created in REM sleep causes sleep paralysis
episodes. Fear conjured by the amygdala causes rapid breathing and
increased heart rate which forms hallucinations. Regular sleep and a
healthy lifestyle are the main treatments.
Doesn't Mr. Pitts want two paragraphs?
Category: My peer edits | Comments: 0 | Rate:
Created By: Daylen Gargalis
Bananas and genetic engineering: Past, present and future
July 12, 2012|By Rosie Mestel, Los Angeles Times | This post has been corrected. See the note below for details.
The Pahang banana -- good for research but not so good for eating because its fruits are full of seeds. Scientists have sequenced its genome. It will help them in their banana biotech and breeding efforts going forward.
The Pahang banana -- good for research but not so good for eating because… (Angelique D'Hont / CIRAD )
Scientists are fighting to protect the hundreds of bananas and plantains people eat around the world from a blizzard of pests: insects, fungi, worms, bacteria and viruses.
They're using old methods and new ones in their fight, as noted in our news story on the successful sequencing of the banana genome by French scientists.
 In Uganda, for example, scientists have been using conventional breeding, crossing fertile wild bananas to local bananas that are eaten. They’re trying to develop resistances to banana blights such as black leaf streak disease, a.k.a. black sigatoka, said Andrew Kiggundu, plant biotechnology research officer at the country’s National Agricultural Research Laboratories Institute in Kawanda. The Black Sigatoka fungus attacks the leaves and can cause production losses of up to 50%.
A hybrid banana resistant to black sigatoka is now being scaled up for distribution for farmers, Kiggundu said.
Uganda is also where the first African field trials for genetically modified bananas took place, starting in 2007. (People in Uganda eat almost a kilo of bananas a day, so it’s a very important food crop.)
The trials were done under carefully controlled field conditions, Kiggundu said, and the bananas showed some limited resistance to black sigatoka in the field, with slower disease progression than regular bananas. But the scientists need the plants to do better. They are going back to the drawing board and rejiggering their technology in the hope that they’ll see improved resistance.
In collaboration with a variety of other researchers around the world, the Uganda team is also working on genetically modified bananas with resistance to nematodes, weevils, bacterial wilt and a mold called Panama disease, as well as higher levels of vitamin A and iron, and delayed ripening.
What is a “resistance gene” anyway? How does a plant ward off pests?
In the case of the black sigatoka field trial, bananas were engineered with rice genes that carry instructions for proteins called chitinases. Chitinases break up molecules called chitin – found in insect skeletons and also the cell walls of fungi.
Bananas genetically modified to fight bacterial wilt make two proteins from sweet pepper. One of them is plant ferrodoxin-like protein. It triggers a strong response when plants are attacked by pathogens. The plant, in this response, essentially kills off its own tissue around the site of the infection. At the same time, lots of highly reactive oxygen species are produced, which can attack the invader. And the plant starts making antimicrobial chemicals.
To name just two examples.
 Plants naturally have genetic resistances because they are constantly fighting off pests in the wild. And that includes many wild bananas. Since the genome of one wild banana, a subspecies of Musa acuminata (Pahang), has now been sequenced, researchers hope in the future that some of the genes that they use for engineering resistance and other qualities will come from bananas themselves. Variability exists aplenty in bananas -- it's just hellish to breed traits into the ones people like to eat because the edible ones are not fertile.
Bananas were once explored for another biotech use: creating edible vaccines against various human diseases. Charles Arntzen, a plant biotechnologist at Arizona State University, had in mind producing bananas engineered to make a protein from the bacterium that causes cholera.
This protein doesn't cause disease "but it's a very good vaccine," Arntzen said. The bananas would be harvested and made into chips and powder and these would be given to people in developing countries who don't have good access to modern vaccines. The banana chips, once eaten, would expose the body to the cholera protein and offer resistance later on to encounters with the cholera bacterium.
Arntzen once had high hopes for the concept (he worked on something similar in tomatoes), but the regulatory hurdles for an edible vaccine plus the money needed for safety trials made the whole endeavor too complicated, he said. He and most others have abandoned the effort and moved on to growing non-edible vaccines in tobacco plants.
The remaining edible vaccine efforts are mostly for delivery to fish and other animals, Arntzen said.
You can read lots more about bananas at the following websites:
The banana website for the nonprofit group Bioversity International; the International Magazine on Banana and Plantain (if it’s not already on your coffee table); Uganda’s National Banana Research Program; the book “Banana: The Fate of the Fruit that Changed the World.”
And a review at the state of the banana by Pat Heslop-Harrison and Trude Schwarzacher, "Domestication, Genomics and the Future for Banana."
[For the record, 12:30 p.m. July 13: An earlier version of this post incorrectly said that Charles Arntzen works at Northern Arizona University. Arntzen works at Arizona State University.]
Category: Resarch source spring paper | Comments: 0 | Rate:
Created By: Daylen Gargalis
Scientists Genetically Engineer Human Cells to Fight Cancer
More Sharing ServicesShare
Share on emailEmail
- / +
By SIRI NILSSON
Aug. 31, 2006
Seven years ago, Mark Origer was diagnosed with a malignant melanoma, a sometimes curable skin cancer that can be deadly if it spreads to other parts of the body.
Watch the full report tonight on "World News With Charles Gibson"
By 2004, his cancer had spread to his liver, lung and lymph nodes.
Origer, 53, was optimistic about a cure, but conventional treatments failed him.
"I was hopeful every time I tried a new treatment. I hoped it would be the end of my disease," Origer said.
But nothing worked.
"It felt defeating," he said.
Desperate for a cure, Origer enrolled in a clinical trial at the National Cancer Institute in Bethesda, Md. The trial tested a very experimental therapy that had never before been used in people.
First Human Gene Therapy for Cancer
What attracted Origer, of Waterville, Wis., to the cancer institute was a unique process where genetic engineering is applied to humans.
The process is usually associated with hybrid animals and super foods, but is being tested to fight diseases in people.
The cancer institute's researchers are using genetically engineered immune cells to shrink tumors in cancer patients like Origer.
"This is the first gene therapy for cancer. … That is why it is so important," said Dr. Steven A. Rosenberg, who headed the trial as chief of surgery at the National Cancer Institute.
 Researchers took immune system cells from the blood of 17 advanced melanoma patients who, like Origer, had not been helped by conventional treatments. Origer had only three months to four months left to live when the experimental treatment began.
These ordinary blood cells, called T cells, were genetically engineered to become cancer-fighting cells that could recognize and attack the life-threatening melanoma.
The cancer-fighting cells were then injected back into each patient. Researchers hoped that the new T cells would multiply and fight off the cancers.
Scientific Advance, a Lifesaver for Some
The experimental therapy could be a major medical and scientific advance.
The therapy is also important because, for Origer, it worked.
After he was injected with his own engineered cancer-fighting T cells, he was dismissed from the hospital.
Doctors told him they would know within a month whether the therapy had worked.
"There was a lot of anxiety and apprehension that month," Origer said. "I felt like a gladiator in the arena when I was waiting to see that doctor. I was waiting for 'thumbs up' or 'thumbs down.'"
He received the thumbs up.
"Oh, it was euphoric," Origer said. "It really was."
 Doctors said that Origer's tumors had shrunk by 50 percent after one month, including those that had spread to his liver and other parts of his body.
He was one of two patients on the trial to be declared disease free, even 18 months after the experimental therapy had started.
Not all of the patients were helped by the therapy -- the other 15 died from their disease.
Some Success, Questions Still Linger
Researchers are not sure exactly why the therapy did not work for everyone. They speculate that the cancer cells may have mutated so the cancer-fighting T cells could not recognize them.
The therapy could also have potential side effects, though Origer said he had not had any unusual side effects.
Dr. Patrick Hwu, chairman of melanoma medical oncology at the University of Texas' M.D. Anderson Cancer Center, expressed concerns that these tumor-fighting T cells might turn around and attack the patients' own tissues.
 "T cells are being genetically modified to recognize receptors on the specific cancer cells and to attack those receptors. One must remember that cancer arises from normal tissue," he said. "The side effect could potentially be that the T cells will attack normal tissue that has those same receptors."
Obviously, scientists still have a lot to learn about this approach.
Hwu said, "It is not ready to be used in common practice."
Researchers will keep working on it, though.
"In the future, we plan to perform further trials with patients who have breast, lung or ovarian cancer, but these trials have not begun," Rosenberg said.
This experimental treatment may not be ready for common practice, but it gives science a potential, new approach to cancer therapy.
Category: Resarch source spring paper | Comments: 0 | Rate: